Introduction - PCSK9 inhibitors: the next chapter in CVD prevention.
Topic:
Atherosclerosis
Sponsored by Amgen GmbH.
Event:
ESC Congress 2017
Congress Presentation
4 more presentations in this session
Future perspectives in lipid lowering and CVD prevention.
Speaker: Professor P. Sever (London, GB)
Panel discussion - PCSK9 inhibitors: the next chapter in CVD prevention.
Speaker: Professor J. Chapman (Paris, FR)
Close - PCSK9 inhibitors: the next chapter in CVD prevention.
Speaker: Professor J. Chapman (Paris, FR)
Access the full session
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention
Speakers:
Professor M. Sabatine, Professor P. Sever, Professor J. Chapman, Professor J. Chapman
About the event
ESC 365 is supported by
